| scholarly article | Q13442814 |
| P356 | DOI | 10.2337/DIAB.39.9.1116 |
| P698 | PubMed publication ID | 2384191 |
| P50 | author | Lewis Kuller | Q88077314 |
| Dorothy J Becker | Q100478508 | ||
| Allan L. Drash | Q4730760 | ||
| P2093 | author name string | D Ellis | |
| T J Orchard | |||
| R E LaPorte | |||
| J S Dorman | |||
| R E Maser | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| complications of diabetes mellitus | Q4198677 | ||
| P304 | page(s) | 1116-1124 | |
| P577 | publication date | 1990-09-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II | |
| P478 | volume | 39 |
| Q34924935 | 20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway |
| Q67975670 | A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 (insulin-dependent) diabetic patients |
| Q37370524 | Adiposity and mortality in type 1 diabetes |
| Q59611538 | Anti-Müllerian hormone and its relationships with subclinical cardiovascular disease and renal disease in a longitudinal cohort study of women with type 1 diabetes |
| Q38014361 | Anti-fibrosis therapy and diabetic nephropathy |
| Q33602249 | Are hemoglobin levels elevated in type 1 diabetes? |
| Q36629520 | Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin Diabetes Registry Study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy |
| Q36290898 | Associated factors of diabetic retinopathy in patients that referred to teaching hospitals in Babol |
| Q36999334 | Association of CFH and CFB gene polymorphisms with retinopathy in type 2 diabetic patients |
| Q92424649 | Association of Constipation with risk of end-stage renal disease in patients with chronic kidney disease |
| Q40474030 | Association of Diabetic Neuropathy with Duration of Type 2 Diabetes and Glycemic Control. |
| Q37071619 | Beneficial effects of previous exercise training on renal changes in streptozotocin-induced diabetic female rats. |
| Q33728352 | Betacellulin Induces Increased Retinal Vascular Permeability in Mice |
| Q71564783 | Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study |
| Q36074058 | Caffeine Consumption Contributes to Skin Intrinsic Fluorescence in Type 1 Diabetes |
| Q37314740 | Cardiovascular risk in type 1 diabetes mellitus |
| Q34721194 | Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes |
| Q36928042 | Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). |
| Q91745701 | Clinical Features and Comorbidities of Patients With Necrobiosis Lipoidica With or Without Diabetes |
| Q52037003 | Cognitive dysfunction in adults with type 1 (insulin-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications. |
| Q48274130 | Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro- and macrovascular complications |
| Q91955622 | Comparison of diabetic nephropathy between male and female eNOS-/- db/db mice |
| Q34799273 | Consistency of microvascular and autonomic abnormalities in diabetes |
| Q33585713 | Contribution of sex hormones in the progression of diabetic microvascular diseases |
| Q36415829 | Coronary heart disease in women: why the disproportionate risk? |
| Q71572861 | Coronary heart disease incidence in diabetic patients, and its relationship to general risk factors |
| Q45260568 | Cost-effectiveness of the screening and treatment of diabetic retinopathy. What are the costs of underutilization? |
| Q48320277 | Cumulative Kidney Complication Risk by 50 Years of Type 1 Diabetes: The Effects of Sex, Age, and Calendar Year at Onset |
| Q33930322 | Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes: a nationwide population-based cohort study |
| Q33204471 | Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications Study |
| Q37364755 | Determining the Prevalence of Retinopathy and Its Related Factors among Patients with Type 2 Diabetes in Kerman, Iran. |
| Q35560878 | Development of Diabetes Mellitus Several Years after Manifestation of Diabetic Nephropathy: Case Report and Review of Literature |
| Q74589229 | Development of proliferative retinopathy in patients with long-standing insulin-dependent diabetes mellitus |
| Q34830905 | Diabetes-related microvascular and macrovascular diseases in the physical therapy setting |
| Q33583018 | Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis |
| Q51071301 | Diabetic kidney disease: world wide difference of prevalence and risk factors. |
| Q34357291 | Diabetic nephropathy and chronic kidney disease at a busy diabetes clinic: a study of outpatient care and suggestions for improved care pathways at a subspecialty specialist diabetic renal clinic |
| Q36973440 | Diabetic nephropathy in children and adolescents |
| Q31056855 | Diabetic neuropathy and axon reflex-mediated neurogenic vasodilatation in type 1 diabetes |
| Q31793083 | Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project |
| Q36477778 | Differential effect of glycemia on the incidence of hypertension by sex: the epidemiology of diabetes complications study |
| Q34106397 | Do plant sterol concentrations correlate with coronary artery disease in type 1 diabetes? A report from the Pittsburgh Epidemiology of Diabetes Complications Study |
| Q73455432 | Do tissue plasminogen activator-plasminogen activator inhibitor-1 complexes relate to the complications of insulin-dependent diabetes mellitus? Pittsburgh Epidemiology of Diabetes Complications Study |
| Q34976386 | Does diabetes-related distress explain the presence of depressive symptoms and/or poor self-care in individuals with Type 1 diabetes? |
| Q35911582 | Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study |
| Q36782847 | Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial |
| Q35024764 | End-stage renal disease and survival in people with diabetes: a national database linkage study |
| Q77764997 | Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort |
| Q34330907 | Epidemiology of diabetic retinopathy and macular oedema: a systematic review |
| Q33735651 | Epidemiology of peripheral neuropathy |
| Q35083922 | Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db/db mice |
| Q35228627 | Estrogens and the diabetic kidney |
| Q44954807 | Follow-up of kidney biopsies in normoalbuminuric patients with type 1 diabetes |
| Q37281771 | Frontal gray matter atrophy in middle aged adults with type 1 diabetes is independent of cardiovascular risk factors and diabetes complications |
| Q34080307 | Getting heavier, younger: trajectories of obesity over the life course |
| Q71844722 | Good Blood Glucose Control Characterizes Patients Without Retinopathy After Long Diabetes Duration |
| Q93341008 | Greater progression of coronary artery calcification is associated with clinically relevant cognitive impairment in type 1 diabetes |
| Q34051581 | Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes |
| Q37429200 | Haptoglobin genotype and renal function decline in type 1 diabetes |
| Q36802286 | High glucose blocks the effects of estradiol on human vascular cell growth: differential interaction with estradiol and raloxifene |
| Q35302241 | High-density lipoprotein cholesterol in diabetes: is higher always better? |
| Q41726958 | ISN Forefronts Symposium 2015: Nuclear Receptors and Diabetic Nephropathy |
| Q47138303 | Identifying Patterns of Lifestyle Behaviors among People with Type 2 Diabetes in Tianjin, China: A Latent Class Analysis |
| Q33805724 | Imbalance in sex hormone levels exacerbates diabetic renal disease |
| Q34669819 | In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. |
| Q34459819 | Increase in GLUT1 in Smooth Muscle Alters Vascular Contractility and Increases Inflammation in Response to Vascular Injury |
| Q46473170 | Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects |
| Q30443785 | Inflammatory mechanisms of diabetic complications |
| Q39118882 | Insights into Diabetic Kidney Disease Using Urinary Proteomics and Bioinformatics |
| Q33833060 | Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes? |
| Q43209206 | Kidneys in chronic liver diseases |
| Q55409724 | Knowledge, attitudes, and practice behaviors of medical specialists for the relationship between diabetes and periodontal disease: A questionnaire survey. |
| Q49794561 | Left ventricular systolic dysfunction predicts long-term major microvascular complication outcomes in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications (EDC) study of childhood onset diabetes |
| Q44438940 | Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 Diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study |
| Q36873449 | Longitudinal prevalence of hypertension, proteinuria, and retinopathy in dogs with spontaneous diabetes mellitus |
| Q80218166 | Low cumulative incidence of proliferative retinopathy in childhood-onset type 1 diabetes: a 24-year follow-up study |
| Q46778997 | Medication dosing errors for patients with renal insufficiency in ambulatory care |
| Q68032081 | Microalbuminuria |
| Q33269264 | Microalbuminuria among Type 1 and Type 2 diabetic patients of African origin in Dar Es Salaam, Tanzania |
| Q40431039 | Microalbuminuria: Prognostic and Therapeutic Implications in Diabetic and Hypertensive Pregnancy |
| Q72401492 | Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study |
| Q37780987 | Microvascular disease in children and adolescents with type 1 diabetes and obesity |
| Q34501860 | Midkine, a heparin-binding protein, is increased in the diabetic mouse kidney postmenopause. |
| Q34499008 | Misinterpretation with norm-based scoring of health status in adults with type 1 diabetes |
| Q33835519 | Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience ( |
| Q72643698 | Nerve conduction velocity in man: influence of glucose, somatostatin and electrolytes |
| Q37630036 | Newly diagnosed diabetes mellitus patients presenting with proliferative diabetic retinopathy as an initial sign |
| Q26786923 | Non-Proteinuric Diabetic Nephropathy |
| Q89499530 | Older age of childhood type 1 diabetes onset is associated with islet autoantibody positivity >30 years later: the Pittsburgh Epidemiology of Diabetes Complications Study |
| Q40545183 | Pancreatic disorders of pregnancy. Pregestational diabetes. |
| Q35446651 | Predicting major outcomes in type 1 diabetes: a model development and validation study |
| Q37423520 | Prediction of proliferative diabetic retinopathy with hemoglobin level |
| Q36793264 | Predictors of and survival after incident stroke in type 1 diabetes |
| Q57657558 | Prevalence of nephropathy in type 1 diabetes in the Arab world: A systematic review and meta-analysis |
| Q36392791 | Progression of coronary artery calcium in type 1 diabetes mellitus |
| Q33555198 | Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule |
| Q50546912 | Proliferative retinopathy and proteinuria predict mortality rate in type 1 diabetic patients from Fyn County, Denmark. |
| Q35686583 | Pulse wave analysis and cardiac autonomic neuropathy in type 1 diabetes: a report from the Pittsburgh Epidemiology of Diabetes Complications Study |
| Q72249260 | Quality of centralized diabetes care: a population-based study in the German Democratic Republic 1989-1990 |
| Q35520625 | Recent advances in diabetic nephropathy |
| Q90152592 | Recent trends over time in vascular disease in type 1 diabetes: insights from the Pittsburgh Epidemiology of Diabetes Complications study |
| Q34057903 | Regional adiposity and risk for coronary artery disease in type 1 diabetes: does having greater amounts of gluteal-femoral adiposity lower the risk? |
| Q36643969 | Relationship of Vascular Factors on Electrophysiologic Severity of Diabetic Neuropathy |
| Q73114893 | Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study |
| Q91672915 | Retinopathy progression and the risk of end-stage kidney disease: results from a longitudinal Japanese cohort of 232 patients with type 2 diabetes and biopsy-proven diabetic kidney disease |
| Q64911710 | Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes. |
| Q37741779 | Role of triglyceride-rich lipoproteins in diabetic nephropathy |
| Q92642669 | Screening model for diabetic retinopathy among patients with type 1 diabetes attending a tertiary care setting in India |
| Q34995355 | Serum amyloid a truncations in type 2 diabetes mellitus |
| Q36782619 | Sex differences in renal responses to hyperglycemia, L-arginine, and L-NMMA in humans with uncomplicated type 1 diabetes |
| Q35242806 | Sex differences in the development of kidney disease in individuals with type 1 diabetes mellitus: a contemporary analysis |
| Q37162313 | Sex, diabetes and the kidney |
| Q36884838 | Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study |
| Q33905029 | Skin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes |
| Q34718237 | Skin intrinsic fluorescence correlates with autonomic and distal symmetrical polyneuropathy in individuals with type 1 diabetes |
| Q33626142 | Spinal cord stimulation in experimental chronic painful diabetic polyneuropathy: Delayed effect of High-frequency stimulation |
| Q37275455 | Standardized Documentation in Pediatric Diabetology: Experience From Austria and Germany. |
| Q72053247 | Subclinical nerve dysfunction in children and adolescents with IDDM |
| Q40651811 | Subjective sleep disturbances and glycemic control in adults with long-standing type 1 diabetes: The Pittsburgh's Epidemiology of Diabetes Complications study |
| Q36234919 | Sugar, sex, and TGF-β in diabetic nephropathy |
| Q36152961 | Test characteristics of the ankle-brachial index and ankle-brachial difference for medial arterial calcification on X-ray in type 1 diabetes |
| Q36775788 | Testosterone and cardiac mass and function in men with type 1 diabetes in the Epidemiology of Diabetes Interventions and Complications Study (EDIC). |
| Q45981552 | The Additional Costs and Health Effects of a Patient Having Overweight or Obesity: A Computational Model. |
| Q36600400 | The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes |
| Q35119200 | The assessment of clinical distal symmetric polyneuropathy in type 1 diabetes: a comparison of methodologies from the Pittsburgh Epidemiology of Diabetes Complications Cohort |
| Q44431576 | The effect of sex on endothelial function responses to clamped hyperglycemia in type 1 diabetes |
| Q38396875 | The genetics of diabetic complications |
| Q35004339 | The haptoglobin 1 allele correlates with white matter hyperintensities in middle-aged adults with type 1 diabetes |
| Q45199710 | The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study. |
| Q93061506 | The role of coronary artery calcification testing in incident coronary artery disease risk prediction in type 1 diabetes |
| Q67595214 | Thromboxane in the pathogenesis of glomerular injury in diabetes |
| Q35688911 | Treatment of hypertension and microalbuminuria in children and adolescents with type 1 diabetes mellitus |
| Q50091909 | Trends in cardiovascular risk factor management in type 1 diabetes by sex. |
| Q44970747 | Ultrastructural alterations in capillaries of the diabetic hypertensive rat retina: protective effects of ACE inhibition |
| Q89808232 | Understanding Metabolic Memory: A Tale of Two Studies |
| Q64981581 | Urinary Plasmin(ogen) as a Prognostic Factor for Hypertension. |
| Q34413638 | Using skew-symmetric mixed models for investigating the effect of different diabetic macular edema treatments by analyzing central macular thickness and visual acuity responses |
| Q34382202 | Variants of the adenosine A(2A) receptor gene are protective against proliferative diabetic retinopathy in patients with type 1 diabetes |
Search more.